NurOwn and the Hope for Stem Cells in ALS?

Update: 2019-10-15

Description

On this episode of the Endpoints, Dr. Steve Perrin, CEO at ALS TDI answers questions about one of the most talked about clinical trials in ALS at the moment, Brainstorm Cell Therapeutics’ NurOwn, a proposed stem-cell-based treatment. The therapy focuses on the cellular support system around a person with ALS’ motor neurons. It aims to slow disease progression by replacing the damaged system with an enhanced one.

To listen to more episodes of the Endpoints Podcast, click here.

Support the show: https://www.als.net/donate/

See omnystudio.com/listener for privacy information.

Comments

In Channel

Lou Gehrig Day: Celebrating a Legend and Raising ALS Awareness

2021-05-1422:11

Braingate: Helping People with ALS Control Devices with their Minds

2021-02-2627:31

The Lloyd Brothers: Racing for ALS

2020-02-0719:46

What to Know About CMAP

2020-01-2716:30

What to know about AMX0035

2019-10-3108:34